Opportunities Galore for India’s Biotech Industry
India is an attractive destination for biotech enterpreneurs from across the globe and local companies are prising open this door…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
M&A or MIA?
After witnessing watershed deals in the past few years, the M&A scenario in India seems to be MIA: Missing in Action. However,…
Beyond The Ban
The Government of India recently banned the use of serology-based test kits for diagnosis of tuberculosis. But this will translate…
CDSCO Draft Guidelines: Industry gives its verdict
Recently, the Central Drugs Standard Control Organisation (CDSCO) called for recommendations and suggestions on its draft…
DCGI to be competent national authority to certify API exports to EU
Draft guidelines for certification as per Falsified Medicines Directive, to be finalised by Jan 2013
Re booting for 2013 …
Piramal Enterprises' second buy in the pharmaceutical analytics sector, the UK-based Abacus International, is an indicator of the…
Aurobindo Pharma receives US FDA approval for HIV drug
To manufacture and market the earlier tentatively approved Abacavir tablets
DIA appoints Jytte Lyngvig as new European director
She is expected to take up her new position on January 10, 2013
State drug regulators equally responsible for clinical trial activities: DCGI
In a watchdog role, state regulators now mandated to accompany CDSCO officers on clinical trial site inspections
Panacea Biotec gets GoI’s order for supply of oral polio vaccine worth Rs 187 cr
It will supply 125 million doses of tOPV in December 2012 and 70 million doses of tOPV in January 2013 for the National…